PedAM
Pediatric Disease Annotations & Medicines
| Disease | schizophrenia |
| Symptom | C0392156|akathisia |
| Sentences | 4 |
| PubMedID- 20416096 | Very recently, we reported that fluvoxamine is also effective in the treatment of aripiprazole-induced akathisia in patients with schizophrenia . |
| PubMedID- 20205742 | Methods: we report on two cases in which monotherapy of the selective serotonin reuptake inhibitor and sigma-1 receptor agonist fluvoxamine was effective in ameliorating the akathisia of patients with schizophrenia treated with the antipsychotic drug aripiprazole. |
| PubMedID- 20008446 | Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar i disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. |
| PubMedID- 22701324 | A recent review of clinical trials assessing the occurrence of akathisia in patients with schizophrenia and schizoaffective disorders reported mild to moderate akathisia in 9% of aripiprazole-treated and 6% of placebo-treated patients, 12.5% of aripiprazole-treated versus 24% of haloperidol-treated patients, and 11% of aripiprazole-treated versus 6% of olanzapine-treated patients. |
Page: 1